DUBLIN–(BUSINESS WIRE)–The “Bioactive Peptide Market, by Source, by Therapeutic Area, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.
Bioactive peptides are a group of biological molecules that are normally buried in the structure of parent proteins and become active after the cleavage of the proteins. Another group of peptides is actively produced and found in many microorganisms. Many groups of bioactive peptides have been marketed chemically or recombinantly.
The bioactive peptides are ingredients that provide nutritive value to the food by adding protein and other important nutrients. Bioactive peptides are gaining popularity, owing to health benefits such as prevention and control of chronic disease conditions like cardiovascular disease, diabetes, cancer, and infectious diseases. Therefore, bioactive peptides are used as treatment therapy for most of the functional disorders such as irritable bowel disease, which is expected to drive the market growth.
Market Dynamics
Increasing research and development by key market players for the treatment of pulmonary edema and rheumatoid arthritis is expected to drive growth of the global bioactive peptide market over the forecast period. For instance, on May 30, 2022, APEPTICO Forschung und Entwicklung GmbH, a biotechnology company, announced that the 3-D structure and the mechanism of action of Solnatide,( a dry powder inhalation and an inhaled aerosol formulation of a synthetic peptide) a possible treatment for pulmonary oedema, had been disclosed by an international network of scientists led by APEPTICO.
Key features of the study:
This report provides in-depth analysis of the global bioactive peptide market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 – 2030, considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global bioactive peptide market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global bioactive peptide market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global bioactive peptide market
Detailed Segmentation:
Global Bioactive Peptide Market, By Source:
Plant
Milk
Egg
Meat
Fish
Others (Bacterial Antimicrobial Peptides and Venom Peptidomics)
Global Bioactive Peptide Market, By Therapeutic Area:
Antihypertensive
Antioxidant
Immunostimulatory
Antimicrobial
Diabetes
Others( Gastrointestinal System and Cardiovascular System)
Global Bioactive Peptide Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others(Drug Store and Mail-Order Pharmacy)
Global Bioactive Peptide Market, By Region:
North America
U.S.
Canada
Europe
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Key Topics Covered:
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Source
Market Snapshot, By Therapeutic Area
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Development
Regulatory Scenario
Reimbursement Scenario
Pest Analysis
Market Potential in Lower economies
4. Global Bioactive Peptide Market- Impact of Coronavirus (Covid-19) Pandemic
Overall Impact
COVID-19 Impact on the market
5. Global Bioactive Peptide Market, By Source, 2017 – 2030, (US$ Million)
6. Global Bioactive Peptide Market, By Therapeutic Area,2017 – 2030, (US$ Million)
7. Global Bioactive Peptide Market, By Distribution Channel, 2017 – 2030, (US$ Million)
8. Global Bioactive Peptide Market, By Region, 2017 – 2030, (US$ Million)
9. Competitive Landscape
10. Section
References
Research Methodology
About Us
Companies Mentioned
Archer Daniels Midland Company
Seagarden AS
Phermpep Co. Ltd.
Arlak Biotech Pvt. Ltd.
Naturade
Royal DSMConsort Medical plc
MYOS RENS Technology Inc.
Natural Factors Inc.
Valio Oy
GenScript
HELIX BIOMEDIX
Oryn Therapeutics
Selecta Biosciences
NIBEC
vivitide
PEPTIDE INSTITUTE, INC
BCN Peptides
Setlance srl.
APEPTICO Forschung und Entwicklung GmbH
BIONANOPLUS
For more information about this report visit https://www.researchandmarkets.com/r/xcyj52
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
